Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | etofenamate | 35375 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | etofenamate | 35375 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | etofenamate | 35375 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | 5186223 | None | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | 5186223 | None | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | 5186223 | None | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | 5186223 | None | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | 5186223 | None | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | 5186223 | None | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | 5186223 | None | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | 5186223 | None | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | celastrol | 5478883 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | celastrol | 5478883 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | celastrol | 5478883 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | celastrol | 5478883 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | celastrol | 5478883 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | celastrol | 5478883 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | celastrol | 5478883 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | celastrol | 5478883 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | celastrol | 5478883 | drug-path |